| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208088A2 Fluorene derivatives as integrin inhibitors |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1351581A Novel carboxylic acid derivatives and process for producing the same |
| 05/29/2002 | CN1134400C Novel carboxylic acid derivatives and process for producing the same |
| 05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
| 05/28/2002 | CA2118997C Benzimidazole derivatives, their preparation and use |
| 05/23/2002 | WO2002040019A1 Benzimidazole derivatives |
| 05/23/2002 | US20020061989 Method of controlling polymer molecular weight and structure |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | CA2428787A1 Benzimidazole derivatives |
| 05/22/2002 | EP1206466A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 05/21/2002 | US6392086 Intermediates and process for producing fluorine-containing amino acid compound by using the same |
| 05/21/2002 | US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide |
| 05/21/2002 | US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 05/16/2002 | WO2002038549A1 Hetero-anellated ortho-aminophenols and their use as dye components |
| 05/16/2002 | US20020058811 Naphthalene derivatives |
| 05/16/2002 | US20020058772 Method of controlling polymer molecular weight and structure |
| 05/16/2002 | US20020058666 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands |
| 05/16/2002 | US20020058659 Imidazole compounds |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204644A1 Synthesis of substituted amidines |
| 05/15/2002 | EP1167360A9 Human chymase inhibitors |
| 05/15/2002 | EP0733621B1 Novel imidazole derivative and process for producing the same |
| 05/15/2002 | CN1349511A Benzimidazolrone and analogues, and the use as ligand of progesterone |
| 05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/15/2002 | CN1349411A Compositions containing benzimidazolones and progestogens |
| 05/15/2002 | CN1084746C 1,2,3-benzothiadiazole derivatives |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388004 Aqueous solution of ammonium sulfide containing sodium thiocyanate |
| 05/14/2002 | US6387939 Plant safening agnets; fungicide |
| 05/14/2002 | US6387938 Benzimidazole derivatives |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | CA2075876C Arylethylamines derivatives, process for their preparation and pharmaceutical compositions holding same |
| 05/10/2002 | WO2002036580A2 Benzoxazole lpaat- beta inhibitors and uses thereof |
| 05/10/2002 | WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055532 UV-B filter |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055519 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
| 05/07/2002 | US6384284 Reacting a diphenylbisaldehyde in the presence of a base or lewis acid; photostabilizers for cosmetics and drugs |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6384059 Crystalline form of omeprazole |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | CA2052263C Herbicides |
| 05/02/2002 | WO2002034723A1 Process for preparation of diaminocarbene-transition metal complexes, ruthenium compounds and their usage |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052343 Salicylamides as serine protease inhibitors |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/01/2002 | CN1347413A Crystalline form of omeprazole |
| 05/01/2002 | CN1346826A Microbicidal halobenzoimidazole, composition and process for preparing same |
| 04/30/2002 | US6380392 Complexes |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus. |
| 04/30/2002 | US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy |
| 04/30/2002 | US6380232 For therapy of cancer or a viral infection in warm blooded animals, may be used in combination with potentiator or other drug |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380210 Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| 04/30/2002 | US6380205 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
| 04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
| 04/30/2002 | US6380180 Potassium channel blocking agents |
| 04/30/2002 | US6379882 Exposing a primary culture of retinal ganglion cells to an oxygen/glucose deprivation challenge with and without a test compound; after an incubation period, measure the percentage of apoptotic cells |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032886A1 A process for the preparation of bis-benzazolyl compounds |
| 04/25/2002 | WO2002032877A2 Process for preparation of n-substituted 2-sulfanylimidazoles |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels |
| 04/25/2002 | US20020049238 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 04/25/2002 | US20020049207 Nitrogen containing heterobicyclic compounds for treating disorders manifesting hypersecretion of corticotropin releasign factor(CRF) in a warm-blooded animals, such as stroke |
| 04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/24/2002 | EP1198456A2 Potassium channel openers |
| 04/23/2002 | US6376679 Sunscreen agents; ultraviolet radiation absorber |
| 04/23/2002 | US6376666 2-mercaptobenzimidazole derivatives possessing pharmacological activity |
| 04/23/2002 | US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/18/2002 | WO2002030909A1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans |
| 04/18/2002 | WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins |
| 04/18/2002 | WO2002030886A2 Heterocyclic angiogenesis inhibitors |